Human papillomavirus (HPV) infection causes cervical cancer … Types 6/11/16/18) L1 virus-like
particle (VLP) vaccine or one of two placebo formulations. The goal was to assess vaccine …

… Infection with specific types of human papillomavirus (HPV) causes nearly all cervical
cancers, and improvements in the understanding of the natural history of the disease have …

… mucosal types, chimeric VLPs were generated based on the bovine papillomavirus type 1
L1 … Although these data show that cross-protection can occur after vaccination of rabbits with …

… of human papillomavirus (HPV) in young women before and after HPV vaccine introduction
… bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-…

… Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide. …
HPV vaccination is a safe and effective method against this disease. HPV vaccines provided …

… The impact of human papillomavirus (HPV) vaccination has been observed in the United
States … To further evaluate vaccine impact, we described trends in HPV vaccine types 16/18 in …

… vaccine comprised of a mixture of virus-like particles derived from the L1 capsid proteins of
human papillomavirus (HPV) types … a three-dose vaccine regimen at 0, 1 and 6 months. The …

Background Approximately 20 percent of adults become infected with human papillomavirus
type 16 (HPV-16). Although most infections are benign, some progress to anogenital cancer…

… human papillomavirus (HPV). Two recently developed prophylactic cervical cancer vaccines,
… Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical …

Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …